Research
Is Aggressive Prostate Cancer Increasing Nationwide?
A new DCC study shows a concerning rise in advanced and aggressive prostate cancer diagnoses among U.S. men.
A Potential New Therapeutic Target in Pancreatic Cancer
Dartmouth Cancer Center researchers uncover a mechanism that helps pancreatic cancer cells change identity, providing a potential target for preventing or reversing that process.
New Fluorescence-Guided Surgery Clinical Trial Opens to Patients with Glioblastoma
In this video Q&A, neurosurgeon Linton T. Evans, MD, talks about his new clinical trial to improve surgical outcomes for patients with newly diagnosed glioblastoma brain tumors.
Dartmouth Cancer Center research shows improved treatment outcomes for breast cancer patients using new technology
The Dartmouth Cancer Center Comprehensive Breast Program at Cheshire Medical Center joined 22 other hospitals worldwide in testing a new approach to breast-conservation cancer surgery (lumpectomy) that could make treatment more precise and effective.
Mapping the Immune Cells That Help Tumors—and the Ones That Fight Them
New Dartmouth Cancer Center research finds that some immune cells help organize a response against cancer, while others support tumor growth.
Rethinking Bladder Cancer Surveillance: Can Fewer Procedures Be Just as Effective?
A new national study explores whether fewer invasive bladder exams can safely reduce discomfort and improve quality of life for patients with bladder cancer.
Dartmouth Health launches Division of Resilient and Sustainable Cancer Care
First-of-its-kind initiative to lead national efforts in building climate resilient and sustainable models for cancer treatment
A New Approach to Timely Head and Neck Cancer Treatment in Rural New England
Clinical scientists blend innovation with compassion to move patients with head and neck cancer from surgery to radiation within the window of better outcomes.
Where Do Prouty Donations Go? Spring 2026
How your support is getting brand new research off the ground at Dartmouth Cancer Center.
New Study Finds Common Blood Pressure Drug Boosts Cancer Treatment
Dartmouth Cancer Center researchers find that the common blood pressure medication telmisartan can significantly boost the cancer drug olaparib.